June 26, 2026
Glutathione IV has become one of the most searched and requested treatments in India's wellness and aesthetics market — and one of the most consistently overpromised. Clinics and influencers suggest dramatic skin lightening, instant luminosity, and near-permanent results. The clinical picture is both more nuanced and more interesting than the marketing. Glutathione does genuine work; that work deserves an honest explanation.
Glutathione is your body's own master antioxidant — produced endogenously in every cell but most abundantly in the liver. It is a tripeptide (glycine, cysteine, and glutamate) with three primary functions: neutralising reactive oxygen species before they damage cells and DNA; supporting liver Phase II detoxification; and — most relevant to skin — modulating melanin synthesis by inhibiting tyrosinase and shifting production from eumelanin (darker brown-black pigment) toward phaeomelanin (lighter yellow-pink pigment). This last mechanism is real and measurable. The question is at what dose, through which route, in which patients, and over what timeframe — and whether the evidence matches the marketing claims.
The most credible clinical evidence for glutathione and skin brightening is modest but genuine. A 2012 randomised controlled trial in the Journal of Clinical Biochemistry and Nutrition found 500mg oral glutathione daily over four weeks produced measurable melanin index reductions. A 2017 placebo-controlled trial showed significant skin lightening with IV glutathione at 600-1,200mg per session over multiple sessions. These studies have real methodological limitations — small samples, short follow-up — but the direction of evidence is consistent: glutathione at therapeutic doses, over a sustained course, can produce measurable reduction in skin pigmentation in appropriate patients. What the evidence does not support: single-session dramatic lightening, permanent results, or efficacy without continued treatment and sun protection.
The clearest benefit is in patients with diffuse pigmentation driven by oxidative stress — melasma without a dominant hormonal driver, post-pollution oxidative darkening (very relevant in Mumbai and Pune), and overall dullness from accumulated free radical damage. Glutathione's systemic antioxidant and tyrosinase-inhibiting action targets this mechanism directly.
Patients with focal, deep, dermal post-acne marks benefit less from glutathione IV alone — these require more targeted topical or procedural interventions. Glutathione can complement but not replace those approaches. See: understanding your pigmentation type before committing to any protocol.
A glutathione IV skin programme at ALIV's Pune and Mumbai clinics typically involves weekly or bi-weekly sessions for eight to twelve sessions as the initial course — not one session, not immediate results. Most patients notice the first changes between sessions three and five: improved luminosity and reduced dullness before any measurable lightening. Measurable pigmentation reduction is typically apparent from session six to eight onwards. Results are gradual, cumulative, and dependent on consistent sun protection throughout.
Without SPF 50+ applied consistently, UV exposure reactivates melanin production faster than glutathione inhibits it, and the treatment produces minimal net benefit. This is the most common reason patients report glutathione "didn't work." See the complete protocol context: ALIV skin health and pigmentation pillar.
Glutathione's effect on melanin production is sustained only as long as plasma levels remain elevated — which requires ongoing sessions or robust oral antioxidant support between sessions. Stopping IV glutathione without transitioning to monthly IV or high-quality liposomal oral glutathione typically results in gradual return toward baseline pigmentation over three to six months. This is pharmacological reality, not a side effect. Results require maintenance.
IV glutathione (intravenous) and IM glutathione (intramuscular injection) are different delivery routes. IV delivers directly into the bloodstream, achieving higher plasma concentrations more rapidly. IM absorbs more slowly through muscle tissue. IV is generally preferred at ALIV for the concentration advantage — but both are used in clinical practice. The "gluta push" shots offered at some clinics are a small-volume IV bolus variant. Your ALIV doctor selects the appropriate format for your clinical picture.
No. Glutathione modulates melanin production while plasma levels are therapeutically elevated. Without ongoing maintenance, melanin production returns toward baseline. Permanent skin lightening without ongoing therapy is not a physiologically honest claim. Maintained results with maintained treatment is the correct description.
Yes — at the doses used in skin wellness programmes, glutathione is generally well-tolerated across all skin tones. It does not produce patchy or uneven lightening when administered properly; the systemic mechanism affects melanin production evenly. The concern about uneven results typically arises from inconsistent sun protection during treatment (UV-exposed areas remain darker while protected areas lighten) rather than from the glutathione itself.
Yes — and this combination is standard in ALIV's skin IV formulations. Vitamin C independently inhibits tyrosinase and regenerates oxidised glutathione back to its active reduced form, effectively extending glutathione's working life in the body. The two are synergistic. Read: vitamin C oral vs IV vs topical for skin.
Ask directly: Is this pharmaceutical-grade glutathione in a sterile preparation? What is the milligram dose per session? A legitimate clinical answer is specific. Evasion is the answer you need. The full safety checklist: how to choose an IV clinic in India